Multicenter, non-randomized phase II study with RPR109881 in taxane-exposed metastatic breast cancer (MBC) patients (pts): Final results
暂无分享,去创建一个
G. Romieu | V. Diéras | P. Kaufman | J. Ferrero | A. Buchbinder | A. Lortholary | S. Limentani | M. Besenval | V. Valero | M. Tubiana‐Hulin